摘要 |
<p>This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.</p> |
申请人 |
ABBOTT LABORATORIES;ROCKWAY, TODD W.;BETEBENNER, DAVID A.;DEGOEY, DAVID A.;FLENTGE, CHARLES A.;HUTCHINSON, DOUGLAS K.;KATI, WARREN M.;KRUEGER, ALLAN C.;LIU, DACHUN;LONGENECKER, KENTON L.;PRATT, JOHN K.;STEWART, KENT D.;WAGNER, ROLF |
发明人 |
ROCKWAY, TODD W.;BETEBENNER, DAVID A.;DEGOEY, DAVID A.;FLENTGE, CHARLES A.;HUTCHINSON, DOUGLAS K.;KATI, WARREN M.;KRUEGER, ALLAN C.;LIU, DACHUN;LONGENECKER, KENTON L.;PRATT, JOHN K.;STEWART, KENT D.;WAGNER, ROLF |